| PULMONX CORP. DL-,001 |
| USA |
| Gesundheit |
| US7458481014 / A2P1AF |
| 4NI (Frankfurt) / LUNG (NASDAQ) |
| FRA:4NI, ETR:4NI, 4NI:GR, NASDAQ:LUNG |
| - |
| https://pulmonx.com/ |
|
Pulmonx Corporation is a leading medical technology company specializing in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). The company focuses on developing and commer..
>Volltext.. |
| 54.25 Mio. EUR |
| 36.86 Mio. EUR |
| 79.06 Mio. EUR |
| -48.18 Mio. EUR |
| -48.95 Mio. EUR |
| -1.22 EUR |
| 48.78 Mio. EUR |
| 66.25 Mio. EUR |
| -27.68 Mio. EUR |
| 3.36 |
| 9.68% |
| 5.7% |
| - |
| - |
| - |
| PULMONX |
| 05.03.26 |
|
||||
|